The Pharmaceutical Price Regulation Scheme - Proposals for a new drug pricing mechanism in the NHS are welcomed

被引：6
|
作者：
Collier, Joe [1 ]
机构：
[1] Univ London, St Georges, London SW17 0RE, England
来源：
BRITISH MEDICAL JOURNAL | 2007年 / 334卷 / 7591期
关键词：
D O I：
10.1136/bmj.39136.464421.BE
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：435 / 436
页数：2
相关论文
共 42 条
  • [31] A new scheme of lignin biosynthesis and the mechanism of its regulation of functional properties.
    Semenov D.A.
    Sudachkova N.E.
    Khlebopros R.G.
    Doklady Biochemistry and Biophysics, 2002, 382 (1-6) : 50 - 52
  • [32] New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study
    Croker, Richard
    Walker, Alex J.
    Bacon, Seb
    Curtis, Helen J.
    French, Lisa
    Goldacre, Ben
    BMJ OPEN, 2018, 8 (02):
  • [33] Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004
    Fei-Yuan Hsiao
    Yi-Wen Tsai
    Weng-Foung Huang
    BMC Health Services Research, 10
  • [34] Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004
    Hsiao, Fei-Yuan
    Tsai, Yi-Wen
    Huang, Weng-Foung
    BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [35] Need of the Regulation for Profit Percentage Investment by Pharmaceutical Companies in New Drug Discovery Research from the Various Local Traditional Medicinal and Plant Systems
    Bhattarai, M. D.
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2012, 52 (03) : 148 - 150
  • [36] Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells
    Maria Antonietta Sabatino
    Mirko Marabese
    Monica Ganzinelli
    Elisa Caiola
    Cristina Geroni
    Massimo Broggini
    Molecular Cancer, 9
  • [37] Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells
    Sabatino, Maria Antonietta
    Marabese, Mirko
    Ganzinelli, Monica
    Caiola, Elisa
    Geroni, Cristina
    Broggini, Massimo
    MOLECULAR CANCER, 2010, 9
  • [38] New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent
    Hausheer, FH
    Kochat, H
    Parker, AR
    Ding, DY
    Yao, SJ
    Hamilton, SE
    Petluru, PN
    Leverett, BD
    Bain, SH
    Saxe, JD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (Suppl 1) : S3 - S15
  • [39] New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent
    Frederick H. Hausheer
    Harry Kochat
    Aulma R. Parker
    Daoyuan Ding
    Shije Yao
    Susan E. Hamilton
    Pavankumar N. Petluru
    Betsy D. Leverett
    Stacey H. Bain
    Jeffrey D. Saxe
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 3 - 15
  • [40] New use of an old drug: mechanism of oseltamivir phosphate inhibiting liver cancer through regulation of lipophagy via NEU1
    Chen, Yuyu
    Han, Peiyu
    Zhu, Haixia
    Zhang, Wenchao
    Ma, Xiaoyu
    He, Yiting
    Chen, Hetian
    He, Weiwei
    Wu, Yu
    Ge, Yuqiu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
12345